Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 6115INDUSTRY 2385NIH 579NETWORK 227OTHER_GOV 91FED 59UNKNOWN 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 78Breast 49Thoracic 28Head & Neck 15Lymphoid 14CNS 9Other hematologic neoplasm 7Gynecologic 6Genitourinary 4Dermatologic 4Sarcoma 3Other solid neoplasm 2Other neoplasm 2Tumor-Agnostic 1NET 1Myeloid 1Endocrine 1

Conditions

Urinary Bladder Neoplasms 2Stomach Neoplasms 1Ovarian Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Melanoma 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

pyrotinib 1pembrolizumab 1Trastuzumab 1Sorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Interventional × Genitourinary × Clear all
NCT05318339 2022-04-08

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT02346955 2020-08-27

MK-6018-001

KitovPharma

Phase 1 Terminated
27 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT03672240 2020-07-20

NMIBC

AsierisPharma

Phase 1/2 Completed
6 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01041482 2010-01-06

AGuo

ChineseAMS

Phase 2 Unknown
140 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡